Vindhya Data Science ("Vindhya" or the "Company"), a women-owned leading bioinformatics service provider announced publication of three research reports pertaining to associations between dental/oral ...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it has been named a Houston Top Workplace for 2024 by the Houston Chronicle ...
Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been ...
The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
On November 8, 2024, Roche Diagnostics enhanced the company's long term commitment to China's local healthcare industry, to ultimately benefit patients in China and beyond, with the opening of its ...
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
GlobalData on MSN16h
Roche secures CE mark for ovarian cancer detection testRoche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
Healthcare solutions provider Qure.ai has entered into a collaboration with Roche Diagnostics Asia Pacific’s Startup Creasphere (APAC) initiative to work on AI-driven medical imaging technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback